Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cephalosporin C
- Development stage
- Discontinued
- Lead developer
- Eli Lilly
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Cephalosporin C is a naturally occurring beta-lactam antibiotic of the cephalosporin class, originally isolated from the fungus Acremonium chrysogenum. It was first characterized in 1961 and served as the lead compound for the development of many synthetic cephalosporins, such as cefalotin. Cephalosporin C itself has weak antibacterial activity and was never commercialized as a therapeutic drug. Its mechanism of action involves inhibition of penicillin binding proteins (PBPs), which are enzymes essential for bacterial cell wall synthesis, leading to bactericidal effects. Cephalosporins are generally used to treat various bacterial infections, especially in patients allergic to penicillins[6][9][1].
- Other names
- 7-(5-amino-5-carboxyvaleramido)cephalosporanic acidCHEBI:157763XIY7HJT5L
02
Targets
PBP (Penicillin-binding protein family)
Beyond the preview
Go deeper on cephalosporin C.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cephalosporin C.